Milnacipran is a serotonin and norepinephrine reuptake inhibitor (SNRI) used to manage fibromyalgia, a condition characterized by widespread pain and tenderness. It works by increasing levels of neurotransmitters involved in pain regulation. Its clinical relevance lies in alleviating symptoms of fibromyalgia. In summary, Milnacipran is essential for managing chronic pain conditions.
Milnacipran inhibits the reuptake of serotonin and norepinephrine, enhancing their availability in the central nervous system for pain modulation.